Electron beam melting (EBM) is an additive manufacturing approach, which permits forming custom-made implants that completely match the loss of the anatomical construction of bone. Implantation effectivity relies upon not solely on the implant’s purposeful or mechanical properties but in addition on its floor properties, that are of nice significance with regard to such organic processes as bone regeneration or microbial contamination. This work presents the influence of floor modifications (mechanical sprucing, sandblasting, and acid-polishing) of EBM-produced Ti6Al4V ELI implants on important organic parameters.
These embody wettability, cytotoxicity toward fibroblast and osteoblast cell line, and capability to type biofilm by Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Obtained outcomes indicated that every one ready surfaces exhibited hydrophilic character and the very best adjustments of wettability have been obtained by chemical modification.
All implants displayed no cytotoxicity towards osteoblast and fibroblast cell strains regardless of the modification sort. In flip, the quantitative microbiological assessments and visualization of microbial biofilm by means of electron microscopy confirmed that sort of implant’s modification correlated with the species-specific capability of microbes to type biofilm on it. Thus, the outcomes of the introduced examine verify the connection between such technological facets as floor modification and organic properties. The offered knowledge are helpful with regard to functions of the EBM expertise and current a big step in direction of customized, custom-made implantology observe.
Effects of Postprocess Hot Isostatic Pressing Treatments on the Mechanical Performance of EBM Fabricated TI-6Al-2Sn-4Zr-2Mo
An basically totally acicular alpha-prime martensite inside an equiaxed grain construction was produced in an Electron Beam Melting (EBM)-fabricated Ti-6Al-2Sn-4Zr-2Mo (Ti6242) alloy utilizing two completely different Arcam EBM machines: An A2X system using tungsten filament thermionic electron emission, and a Q20 system using LaB6 thermionic electron emission.
Post-process Hot Isostatic Pressing (HIP) therapy for two h at 850, 950, and 1050 °C resulted in grain refinement and equiaxed grain progress together with alpha-prime martensite decomposition to type an intragranular combination of acicular martensite and alpha at 850 °C, and acicular alpha part at 950 and 150 °C, usually exhibiting a Widmanstätten (basketweave) construction.
The corresponding tensile yield stress and final tensile power (UTS) related to the grain progress and acicular alpha evolution decreased from ~1 and ~1.1 GPa, respectively, for the as-fabricated Ti6242 alloy to ~0.8 and 0.9 GPa, respectively, for HIP at 1050 °C. The optimum elongation of ~15-16% occurred for HIP at 850 °C; for each EBM techniques. Because of the interactive position performed by equiaxed grain progress and the intragrain, acicular alpha microstructures, the hardness diverse solely by ~7% between 41 and 38 HRC.
GP trainees’ perceptions on studying EBM utilizing conversations within the office: a video-stimulated interview examine.
To be capable to observe evidence-based medication (EBM) when making selections for particular person sufferers, it is very important discover ways to mix the most effective accessible proof with the affected person’s preferences and the doctor’s scientific experience. In normal observe coaching, these abilities might be discovered on the office utilizing studying conversations: conferences between the supervising normal practitioner (GP) and GP trainee to debate medical observe, chosen subjects or skilled efficiency.
This examine aimed to offer perception into the perceptions of GP trainees on their EBM studying processes throughout studying conversations.We held semi-structured video-stimulated elicitation interviews (n = 22) with GP trainees affiliated to GP coaching institutes within the Netherlands and Belgium. GP trainees have been proven fragments of their studying conversations, enabling reflection throughout the interview. Taking an inductive strategy, interview recordings have been transcribed verbatim and analysed with NVivo software program.GP trainees perceived studying conversations as helpful for studying and discussing EBM.
Multiple EBM studying actions have been recognized, comparable to discussing proof collectively, relating proof to instances in every day observe and discussing the supervisor’s expertise and the particular native context within the mild of what the proof recommends. However, for studying to happen, trainees want and anticipate particular behaviour, each from their supervisors and themselves. Supervisors ought to provide well-substantiated solutions which can be relevant in observe and give the trainee affirmation.
In flip, the trainee wants to organize effectively as a way to ask centered, in-depth questions. A protected area permitting equal and open dialogue between trainee and supervisor is perceived as an important context for optimum EBM studying.Our findings present that trainees discover studying conversations helpful for EBM studying generally observe. To deliver EBM studying to its full potential, consideration needs to be paid to optimising the behavioural and contextual elements discovered related to enhancing EBM studying.
Application of effect-based strategies (EBMs) in a river basin: a preliminary examine in Central Italy.
Effect-based strategies (EBMs), i.e. in vitro and in vivo bioassays, symbolize revolutionary instruments for the impact detection of environmental chemical pollution on residing organisms. The goal of this examine was to judge the water high quality of a river ecosystem implementing two in vivo bioassays on goal freshwater animal species: the crustacean Daphnia magna and the small fish Danio rerio, also called zebrafish.The strategies utilized on this examine, i.e. the Daphnia sp. Acute Immobilisation assay and the Fish Embryo Acute Toxicity (FET) check, are generally utilized in water high quality analysis and their software in short-term ecotoxicity detection is recommended by current European tasks.
Two sampling websites have been chosen within the city half of the Tiber River in Rome, whereas a 3rd one was chosen as a reference website within the Farfa River, a tributary upstream of the town. The websites within the Tiber River are probably affected by completely different air pollution sources, together with city and industrial wastewater discharges, the pesticide launch, livestock waste merchandise, and waste dumps.
The outcomes of the examine confirmed huge variations between the 2 utilized bioassays. The FET check was usually extra delicate in detecting even low results in all of the water samples, however the strongest statistically outcomes have been noticed with the D. magna Acute Immobilisation check.
The outcomes of this analysis verify the effectiveness of EBMs in investigating and monitoring water chemical air pollution, and stress the necessity for performing additional research, e.g. chemical analyses and different bioassays, to enhance the information of the well being standing of the Tiber River basin.
SIRT CRISPR Knock Out Human HepG2 Cell Line - Clone T3-6 |
T6804 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
FOLR CRISPR Knock Out Human OVCAR3-A1 Cell Line |
T6229 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
mAdrb2 CRISPR Knock Out B16 Cell Line (T1-10) |
T9775 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
MUC16 CRISPR Knock Out Human OVCAR3-A1 Cell Line |
T6230 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Ccl2 CRISPR Knock Out CT26 Cell Line |
T9611 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CXCL8 CRISPR Knock Out L3.6pl Cell Line |
T6220 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CXCL1 CRISPR Knock Out L3.6pl Cell Line |
T6221 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
NR2F6 CRISPR Knock Out Human Jurkat E6.1 Cell Line - Clone T3-10 |
T6822 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
TREM2 CRISPR Knock Out Human THP-1 Cell Line - Clone T1-9 |
T6810 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PTPN6 CRISPR Knock Out Human THP-1 Cell Line - Clone T3-1 |
T6813 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Aldh2 CRISPR Knock Out L929 Cell Line - Clone T3-20 |
T9692 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PTPN11 CRISPR Knock Out NIH/3T3 Cell Line - Clone T4-9 |
T6803 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PRSS21 CRISPR Knock Out Human OVCAR8 Cell Line - Clone T2 C8 |
T6811 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
METTL3 CRISPR Knock Out Caki-1 Cell Line - Clone T2-16 |
T9623 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Nacc1 CRISPR Knock Out ID8 Cell Line (Mouse) - Clone T1-23 |
T9627 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
osbpl2 CRISPR Knock Out NIH/3T3 Cell Line - T1 Polyclonal Pool |
T9682 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
GLT1 CRISPR Knock Out Rat AST Cell Line - Clone T2-1 |
T9678 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Aifm1 CRISPR Knock Out Mouse L929 Cell Line - Clone T2-15-3 |
T9674 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
SEC61G CRISPR Knock Out HCC-LM3 Cell Line - Clone T2-17-5 |
T9746 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
MSLN CRISPR Knock Out Human OVCAR3-A1 Cell Line - Clone T2 C4 |
T6820 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CARMIL1 CRISPR Knock Out Immortalized Human Gingival Fibroblast - hTERT Cell Line - T1-2 |
T6825 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
hPIM1 CRISPR Knock Out SACC-83 Cell Line-T3-9 |
T9787 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Dcx CRISPR Knock Out C6 Cell Line (Rat) - Clone sg4-1 |
T9624 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Cell line gene knock-in and knock-out |
S301 |
101Bio |
- |
EUR 15000 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T1-19 |
T9511 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T3-3 |
T9529 |
ABM |
1x10^6 cells/1.0ml |
EUR 3950 |
SIRT1 Knockout Stable 293T Cell Line |
T3176 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
T47D/GFP Cell Line |
AKR-208 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
Stable Mouse Myeloid-derived Suppressor-like LAL Knock Out (HD1B) Cell Line |
T3187 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
293T Cell Line |
LV010 |
ABM |
1x10^6 |
EUR 450 |
293T [HEK-293T] Cell Line |
CL-0005 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 420 |
|
Description: Homo sapiens, Human |
Mouse NACC1 CRISPR Stable Knockout ID8 Cell Line - Clone T1-23 |
T6826 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
293T/17 Cell Line |
CL-0469 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 500 |
|
Description: Homo sapiens, Human |
293T Cell Lysate (Human embryonic kidney cell line) |
LF-R0006 |
Abfrontier |
200 ul |
EUR 103.2 |
Description: 293T (Human embryonic kidney cell line) Whole Cell Lysate |
BRCA1 CRISPR Stable Knockout Human Fibroblast Cell Line |
T6245 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Blank Promoter Stable Expressing Human 293T Cell Line |
T9618 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PTPRA CRISPR Knockout Immortalized Human Lung Fibroblast Cell Line |
T6827 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Cas9 Expressing 293T Cell Line |
T3251 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 795 |
Human CRISP1 knockout cell line |
ABC-KH3569 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP2 knockout cell line |
ABC-KH3570 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP3 knockout cell line |
ABC-KH3571 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Stable 293T-ATD cell line |
T6340 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Acan CRISPR Knockout RCS Cell Line (Rat) |
T3000 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PTPN6 Stable Knocked Out THP-1 Cell Line |
T6216 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Human CRISPLD1 knockout cell line |
ABC-KH3572 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISPLD2 knockout cell line |
ABC-KH3573 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
MCF-7/Luc Cell Line |
AKR-234 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
SKOV-3/Luc Cell Line |
AKR-232 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
OVCAR-5/RFP Cell Line |
AKR-254 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
Human CRISP1 knockdown cell line |
ABC-KD3569 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP2 knockdown cell line |
ABC-KD3570 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP3 knockdown cell line |
ABC-KD3571 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
SIRT1 Wildtype Stable 293T Cell Line |
T3175 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line) |
AST-7001 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 6 month |
Human CRISPLD1 knockdown cell line |
ABC-KD3572 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISPLD2 knockdown cell line |
ABC-KD3573 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
GFAT1 CRISPR Stable Knockout H1299 Cell Line |
T6199 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
EDC4 CRISPR Stable Knockout HEK293T Cell Line |
T6241 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
DJ-1 CRISPR Stable Knockout HeLa Cell Line |
T6181 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PGC-1α/ERRα Stable 293T Cell Line |
T3060 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 385 |
YBX1 Stable Knockout Human NK/T Cell Line #T3-16 P6 |
T9508 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PDPN CRISPR Stable Knockout COS-7 Cell Line |
T6039 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PD-L1 CRISPR Stable Knockout CT26 Cell Line |
T6237 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PD-L1 CRISPR Stable Knockout MC38 Cell Line |
T6149 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Mouse R-spondin1 Stable 293T Cell Line |
T3156 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
LIMD1-/- CRISPR Stable Knockout HeLa Cell Line |
T6357 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
TARGATT? Knock-in iPSC Generation (Master Cell Line) |
AST-1100 |
Applied StemCell |
1 vial of 1X10^6 cells |
Ask for price |
Description: 6 month |
SLC35A1 CRISPR Stable Knockout CHO-S Cell Line |
T6040 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
CXCL1 & CXCL8 CRISPR Double Knockout L3.6pl Cell Line |
T6047 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
RV-101 |
Cell Biolabs |
1 vial |
EUR 770 |
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
RV-103 |
Cell Biolabs |
1 vial |
EUR 770 |
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
RV-102 |
Cell Biolabs |
1 vial |
EUR 770 |
PFN2 Stable Expressing 293T Cell Line - Polyclonal |
T9606 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Total Protein - Murine Embryonic Stem Cell Line D3 |
CBA-305 |
Cell Biolabs |
500 ?g |
EUR 414 |
Description: - Isolated from mouse ES-D3 cell line
- Presented as 500 µg at 1 mg/mL in NP-40 Solubilization Buffer
|
PLN Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS41 |
ALSTEM |
1 Vial |
EUR 2268 |
AXL CRISPR Stable Knockout HT1080 (1-IV) Cell Line |
T6232 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
AXL CRISPR Stable Knockout HT1080 (3-II) Cell Line |
T6233 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
LRP1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS31 |
ALSTEM |
1 Vial |
EUR 2268 |
AFF2 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS61 |
ALSTEM |
1 Vial |
EUR 2268 |
ABCA7 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS21 |
ALSTEM |
1 Vial |
EUR 2268 |
KCNK3 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS51 |
ALSTEM |
1 Vial |
EUR 2268 |
LLGL1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF) |
iPS71 |
ALSTEM |
1 Vial |
EUR 2268 |
TARGATT? Knock-in CHO Generation Kit (Master Cell Line) |
AST-1200 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 12 month |
TARGATT? Knock-in HEK293 Generation Kit (Master Cell Line) |
AST-1300 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 12 month |
EBM 3'UTR GFP Stable Cell Line |
TU056522 |
ABM |
1.0 ml |
EUR 2799.6 |
Human CRIM1 knockout cell line |
ABC-KH3563 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIM1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP1 knockout cell line |
ABC-KH3564 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP2 knockout cell line |
ABC-KH3565 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP3 knockout cell line |
ABC-KH3566 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPT knockout cell line |
ABC-KH3568 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPAK knockout cell line |
ABC-KH3567 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human 293T Cell Lysate Lyophilized |
IHU293TTLLY200UG |
Innovative research |
each |
EUR 89 |
|
Description: Human 293T Cell Lysate Lyophilized |
Human 293T Cell Lysate Lyophilized |
MBS136608-02mg |
MyBiosource |
0.2mg |
EUR 205 |
Human 293T Cell Lysate Lyophilized |
MBS136608-5x02mg |
MyBiosource |
5x0.2mg |
EUR 745 |
EBM 3'UTR Luciferase Stable Cell Line |
TU006522 |
ABM |
1.0 ml |
EUR 2799.6 |
AAVS1 Positive Control EGIP 293T Reporter Cell Line |
CAS606A-1 |
SBI |
1 Vial |
EUR 726 |
VEGF Promoter Stable Expressing 293T Cell Line - Clone #2 |
T9622 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Human 293T Whole Cell Lysate |
LYSATE0032 |
BosterBio |
200ug |
EUR 180 |
Description: This cell lysate is prepared from human 293T using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
EBM sgRNA CRISPR Lentivector set (Human) |
K0650101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Human CRIM1 knockdown cell line |
ABC-KD3563 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIM1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP1 knockdown cell line |
ABC-KD3564 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP2 knockdown cell line |
ABC-KD3565 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP3 knockdown cell line |
ABC-KD3566 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIPT knockdown cell line |
ABC-KD3568 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPT knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
hCETP shRNA (Target C) Knock Down THP-1 Cell Line-Polyclone |
T9789 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Human CRIPAK knockdown cell line |
ABC-KD3567 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPAK knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human LIN37 knockout cell line |
ABC-KH8476 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN37 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GC knockout cell line |
ABC-KH5948 |
AcceGen |
1 vial |
Ask for price |
Description: Human GC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GK knockout cell line |
ABC-KH6087 |
AcceGen |
1 vial |
Ask for price |
Description: Human GK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HP knockout cell line |
ABC-KH6972 |
AcceGen |
1 vial |
Ask for price |
Description: Human HP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HR knockout cell line |
ABC-KH6992 |
AcceGen |
1 vial |
Ask for price |
Description: Human HR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KL knockout cell line |
ABC-KH7942 |
AcceGen |
1 vial |
Ask for price |
Description: Human KL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KY knockout cell line |
ABC-KH8250 |
AcceGen |
1 vial |
Ask for price |
Description: Human KY knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MB knockout cell line |
ABC-KH9065 |
AcceGen |
1 vial |
Ask for price |
Description: Human MB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F2 knockout cell line |
ABC-KH5009 |
AcceGen |
1 vial |
Ask for price |
Description: Human F2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F3 knockout cell line |
ABC-KH5014 |
AcceGen |
1 vial |
Ask for price |
Description: Human F3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F5 knockout cell line |
ABC-KH5015 |
AcceGen |
1 vial |
Ask for price |
Description: Human F5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F7 knockout cell line |
ABC-KH5016 |
AcceGen |
1 vial |
Ask for price |
Description: Human F7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F8 knockout cell line |
ABC-KH5017 |
AcceGen |
1 vial |
Ask for price |
Description: Human F8 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F9 knockout cell line |
ABC-KH5021 |
AcceGen |
1 vial |
Ask for price |
Description: Human F9 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human AR knockout cell line |
ABC-KH0856 |
AcceGen |
1 vial |
Ask for price |
Description: Human AR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human SI knockout cell line |
ABC-KH13776 |
AcceGen |
1 vial |
Ask for price |
Description: Human SI knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human T knockout cell line |
ABC-KH15011 |
AcceGen |
1 vial |
Ask for price |
Description: Human T knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TF knockout cell line |
ABC-KH15318 |
AcceGen |
1 vial |
Ask for price |
Description: Human TF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TG knockout cell line |
ABC-KH15342 |
AcceGen |
1 vial |
Ask for price |
Description: Human TG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TH knockout cell line |
ABC-KH15368 |
AcceGen |
1 vial |
Ask for price |
Description: Human TH knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human PC knockout cell line |
ABC-KH11173 |
AcceGen |
1 vial |
Ask for price |
Description: Human PC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human XG knockout cell line |
ABC-KH17067 |
AcceGen |
1 vial |
Ask for price |
Description: Human XG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human XK knockout cell line |
ABC-KH17074 |
AcceGen |
1 vial |
Ask for price |
Description: Human XK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CP knockout cell line |
ABC-KH3480 |
AcceGen |
1 vial |
Ask for price |
Description: Human CP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CS knockout cell line |
ABC-KH3611 |
AcceGen |
1 vial |
Ask for price |
Description: Human CS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C2 knockout cell line |
ABC-KH1951 |
AcceGen |
1 vial |
Ask for price |
Description: Human C2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C3 knockout cell line |
ABC-KH2027 |
AcceGen |
1 vial |
Ask for price |
Description: Human C3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C5 knockout cell line |
ABC-KH2074 |
AcceGen |
1 vial |
Ask for price |
Description: Human C5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C6 knockout cell line |
ABC-KH2100 |
AcceGen |
1 vial |
Ask for price |
Description: Human C6 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C7 knockout cell line |
ABC-KH2130 |
AcceGen |
1 vial |
Ask for price |
Description: Human C7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C9 knockout cell line |
ABC-KH2174 |
AcceGen |
1 vial |
Ask for price |
Description: Human C9 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CEL knockout cell line |
ABC-KH2905 |
AcceGen |
1 vial |
Ask for price |
Description: Human CEL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7A knockout cell line |
ABC-KH8477 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7A knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7B knockout cell line |
ABC-KH8478 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7B knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7C knockout cell line |
ABC-KH8479 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7C knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LINS knockout cell line |
ABC-KH8486 |
AcceGen |
1 vial |
Ask for price |
Description: Human LINS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN28A knockout cell line |
ABC-KH8474 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN28A knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN28B knockout cell line |
ABC-KH8475 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN28B knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human NDN knockout cell line |
ABC-KH9930 |
AcceGen |
1 vial |
Ask for price |
Description: Human NDN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human NDP knockout cell line |
ABC-KH9934 |
AcceGen |
1 vial |
Ask for price |
Description: Human NDP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human NEB knockout cell line |
ABC-KH9989 |
AcceGen |
1 vial |
Ask for price |
Description: Human NEB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FRK knockout cell line |
ABC-KH5720 |
AcceGen |
1 vial |
Ask for price |
Description: Human FRK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FRY knockout cell line |
ABC-KH5737 |
AcceGen |
1 vial |
Ask for price |
Description: Human FRY knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FST knockout cell line |
ABC-KH5752 |
AcceGen |
1 vial |
Ask for price |
Description: Human FST knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FTL knockout cell line |
ABC-KH5760 |
AcceGen |
1 vial |
Ask for price |
Description: Human FTL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FTO knockout cell line |
ABC-KH5762 |
AcceGen |
1 vial |
Ask for price |
Description: Human FTO knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FUK knockout cell line |
ABC-KH5768 |
AcceGen |
1 vial |
Ask for price |
Description: Human FUK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FUS knockout cell line |
ABC-KH5773 |
AcceGen |
1 vial |
Ask for price |
Description: Human FUS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FUZ knockout cell line |
ABC-KH5784 |
AcceGen |
1 vial |
Ask for price |
Description: Human FUZ knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FYB knockout cell line |
ABC-KH5795 |
AcceGen |
1 vial |
Ask for price |
Description: Human FYB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human FYN knockout cell line |
ABC-KH5797 |
AcceGen |
1 vial |
Ask for price |
Description: Human FYN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GAA knockout cell line |
ABC-KH5817 |
AcceGen |
1 vial |
Ask for price |
Description: Human GAA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GAK knockout cell line |
ABC-KH5864 |
AcceGen |
1 vial |
Ask for price |
Description: Human GAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GAL knockout cell line |
ABC-KH5865 |
AcceGen |
1 vial |
Ask for price |
Description: Human GAL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GAN knockout cell line |
ABC-KH5901 |
AcceGen |
1 vial |
Ask for price |
Description: Human GAN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GBA knockout cell line |
ABC-KH5934 |
AcceGen |
1 vial |
Ask for price |
Description: Human GBA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GCA knockout cell line |
ABC-KH5949 |
AcceGen |
1 vial |
Ask for price |
Description: Human GCA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GCG knockout cell line |
ABC-KH5955 |
AcceGen |
1 vial |
Ask for price |
Description: Human GCG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GCK knockout cell line |
ABC-KH5959 |
AcceGen |
1 vial |
Ask for price |
Description: Human GCK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GDA knockout cell line |
ABC-KH5974 |
AcceGen |
1 vial |
Ask for price |
Description: Human GDA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GEM knockout cell line |
ABC-KH5999 |
AcceGen |
1 vial |
Ask for price |
Description: Human GEM knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GFY knockout cell line |
ABC-KH6017 |
AcceGen |
1 vial |
Ask for price |
Description: Human GFY knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GGH knockout cell line |
ABC-KH6024 |
AcceGen |
1 vial |
Ask for price |
Description: Human GGH knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GGN knockout cell line |
ABC-KH6025 |
AcceGen |
1 vial |
Ask for price |
Description: Human GGN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GH1 knockout cell line |
ABC-KH6034 |
AcceGen |
1 vial |
Ask for price |
Description: Human GH1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GH2 knockout cell line |
ABC-KH6035 |
AcceGen |
1 vial |
Ask for price |
Description: Human GH2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GHR knockout cell line |
ABC-KH6038 |
AcceGen |
1 vial |
Ask for price |
Description: Human GHR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GIF knockout cell line |
ABC-KH6045 |
AcceGen |
1 vial |
Ask for price |
Description: Human GIF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GIP knockout cell line |
ABC-KH6060 |
AcceGen |
1 vial |
Ask for price |
Description: Human GIP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GK2 knockout cell line |
ABC-KH6088 |
AcceGen |
1 vial |
Ask for price |
Description: Human GK2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GK5 knockout cell line |
ABC-KH6089 |
AcceGen |
1 vial |
Ask for price |
Description: Human GK5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GLA knockout cell line |
ABC-KH6093 |
AcceGen |
1 vial |
Ask for price |
Description: Human GLA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GLS knockout cell line |
ABC-KH6129 |
AcceGen |
1 vial |
Ask for price |
Description: Human GLS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GML knockout cell line |
ABC-KH6159 |
AcceGen |
1 vial |
Ask for price |
Description: Human GML knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GNE knockout cell line |
ABC-KH6191 |
AcceGen |
1 vial |
Ask for price |
Description: Human GNE knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GNS knockout cell line |
ABC-KH6215 |
AcceGen |
1 vial |
Ask for price |
Description: Human GNS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GP2 knockout cell line |
ABC-KH6257 |
AcceGen |
1 vial |
Ask for price |
Description: Human GP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GP5 knockout cell line |
ABC-KH6258 |
AcceGen |
1 vial |
Ask for price |
Description: Human GP5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GP6 knockout cell line |
ABC-KH6259 |
AcceGen |
1 vial |
Ask for price |
Description: Human GP6 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Further outcomes will goal to help the native authorities in adopting measures to scale back and to remove the sources of chemical air pollution within the examine space.